Status | Study |
Not yet recruiting |
Study Name: Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia Condition: Lymphoblastic Leukemia, Acute Adult Date: 2017-04-14 Interventions: Biological: TBI-1501 Phase-I portion: |
Not yet recruiting |
Study Name: Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes Condition: Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma Date: 2014-04-16 Interventions: Drug: Cyclophosphamide or Bendamustine |
Active, not recruiting |
Study Name: Sorafenib and TRC105 in Hepatocellular Cancer Condition: Hepatoma Liver Neoplasms Adenoma, Liver Cell Date: 2011-02-26 Interventions: Drug: TRC 105 15 mg/kg IV ever |
Terminated |
Study Name: Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma Condition: Melanoma Malignant Melanoma Melanoma, Experimental Date: 2009-06-17 Interventions: Drug: DMF5 Melanoma Reactive TIL |
Completed |
Study Name: Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma Condition: Melanoma Malignant Melanoma Melanoma, Experimental Date: 2007-08-06 Interventions: Biological: aldesleukin Given |